Ignite Creation Date:
2024-05-05 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00509236
Status:
COMPLETED
Last Update Posted:
2017-05-12
First Post:
2007-07-27
Brief Title:
Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease MK-0431-073 AM1
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| End-Stage Kidney Disease |
| Diabetes Mellitus Type 2 |
Keywords: